October 02, 2017
1 min read

IOPtima launches Lipitear phospholipid microemulsion

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

IOPtima launched Lipitear, a phospholipid-based microemulsion formed by an aqueous phase and a lipidic phase that helps restore the microenvironment of the ocular surface, the company announced in a press release.

Lipitear also enhances the physiological process of corneal re-epithelization after ocular surgery and reduces the symptoms and signs of ocular surface disorder.

It restores the natural tear film, exhibiting a long-lasting effect on a dry eye by preventing evaporation and lubricating the corneal surface, the release said.

The device is currently marketed in Europe under a CE mark but has not yet been registered in the United States.